D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing's syndrome
D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing's syndrome
复制标题
DOI:
10.1507/endocrj.ej14-0102
复制
发表时间:
2014-10-01
影响因子:
2
通讯作者:
Takahashi, Yutaka
中科院分区:
文献类型:
--
作者:
Fukuoka, Hidenori;Takeuchi, Takehito;Takahashi, Yutaka
Venous thromboembolism (VTE) is frequently associated with hypercortisolemia. This retrospective single-center study aimed to clarify the significance of plasma D-dimer levels for VTE screening in patients with subclinical or overt Cushing's syndrome (soCS). A total of 72 consecutive treatment-naive patients with soCS diagnosed at Kobe University Hospital between 2002 and 2014 were enrolled. Patients with both lower extremity ultrasound and D-dimer measurement data (n = 19) were recruited in study 1 and divided into 2 groups, a deep vein thrombosis (DVT) (-) group (n = 12) and DVT (+) group (n = 7) for a comparison of the associated factors. The age and D-dimer levels were higher in the DVT (+) group than in the DVT (-) group (p = 0.04 and 0.02, respectively). A receiver operating characteristic analysis found that D-dimer level >= 2.6 mu g/mL correlated with the presence of DVT (sensitivity, 100%; specificity, 91.7%). Next, patients with D-dimer measurement data (n = 36) were recruited in study 2 and divided into 2 groups according to D-dimer level: D-dimer (-), = 1 mu g/mL group (n = 13); the groups were compared with respect to various VTE-related risk factors. A logistic regression analysis revealed that elevated cortisol level after low-dose dexamethasone suppression was a significant risk factor for D-dimer elevation (OR = 1.21, p = 0.02). In conclusion, these data demonstrate that a D-dimer level >= 2.6 mu g/mL is an indicator of DVT in treatment naive patients with soCS and suggests that relatively high autonomous cortisol secretion may be associated with thrombus formation.